Ashwin S. Kumar

997 total citations · 2 hit papers
30 papers, 559 citations indexed

About

Ashwin S. Kumar is a scholar working on Oncology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ashwin S. Kumar has authored 30 papers receiving a total of 559 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Molecular Biology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ashwin S. Kumar's work include Cancer Immunotherapy and Biomarkers (6 papers), Pericarditis and Cardiac Tamponade (4 papers) and Cancer Cells and Metastasis (3 papers). Ashwin S. Kumar is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Pericarditis and Cardiac Tamponade (4 papers) and Cancer Cells and Metastasis (3 papers). Ashwin S. Kumar collaborates with scholars based in United States, Switzerland and Cyprus. Ashwin S. Kumar's co-authors include Rakesh K. Jain, Ümit V. Çatalyürek, Doruk Bozdağ, Dai Fukumura, Triantafyllos Stylianopoulos, Junichiro Yamauchi, Mahasweta Girgenrath, Zohreh Amoozgar, Dennis Jones and William W. Ho and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and The Journal of Experimental Medicine.

In The Last Decade

Ashwin S. Kumar

24 papers receiving 550 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stroma

2019 198 citations Dennis Jones, Hadi T. Nia et al. Proceedings of the National Academy of Sciences profile →
Using mathematical modelling and AI to improve delivery and efficacy of therapies in cancer

2025 19 citations Chrysovalantis Voutouri, Ashwin S. Kumar et al. Nature reviews. Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ashwin S. Kumar United States	11	210	198	112	76	62	30	559
Dan G. Duda United States	5	259 1.2×	200 1.0×	151 1.3×	139 1.8×	143 2.3×	8	736
Ursula Kohlhofer Germany	16	225 1.1×	150 0.8×	86 0.8×	74 1.0×	97 1.6×	30	663
Naita M. Wirsik Germany	9	143 0.7×	220 1.1×	91 0.8×	43 0.6×	86 1.4×	22	443
Haibin Wu China	13	249 1.2×	145 0.7×	134 1.2×	56 0.7×	101 1.6×	32	513
Filip Roudnicky Switzerland	13	388 1.8×	217 1.1×	186 1.7×	50 0.7×	87 1.4×	29	720
Jessica M. Posada United States	10	226 1.1×	354 1.8×	263 2.3×	97 1.3×	128 2.1×	18	707
Florence T.H. Wu United States	14	442 2.1×	214 1.1×	102 0.9×	55 0.7×	156 2.5×	24	739
Yoshihiro Otani Japan	15	373 1.8×	329 1.7×	95 0.8×	54 0.7×	119 1.9×	65	853
Rajiv Magge United States	17	218 1.0×	155 0.8×	75 0.7×	104 1.4×	118 1.9×	50	1.0k
Priyakshi Kalita‐de Croft Australia	14	360 1.7×	131 0.7×	101 0.9×	45 0.6×	136 2.2×	25	594

Countries citing papers authored by Ashwin S. Kumar

Since Specialization

Citations

This map shows the geographic impact of Ashwin S. Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashwin S. Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashwin S. Kumar more than expected).

Fields of papers citing papers by Ashwin S. Kumar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashwin S. Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashwin S. Kumar. The network helps show where Ashwin S. Kumar may publish in the future.

Co-authorship network of co-authors of Ashwin S. Kumar

This figure shows the co-authorship network connecting the top 25 collaborators of Ashwin S. Kumar. A scholar is included among the top collaborators of Ashwin S. Kumar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashwin S. Kumar. Ashwin S. Kumar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nia, Hadi T., Meenal Datta, Ashwin S. Kumar, et al.. (2025). Solid Stress Estimations via Intraoperative 3D Navigation in Patients with Brain Tumors. Clinical Cancer Research. 31(16). 3571–3580. 1 indexed citations

Voutouri, Chrysovalantis, et al.. (2025). Using mathematical modelling and AI to improve delivery and efficacy of therapies in cancer. Nature reviews. Cancer. 25(5). 324–340. 19 indexed citations breakdown →

Lee, Somin, Zohreh Amoozgar, Sonu Subudhi, et al.. (2025). Wnt inhibition alleviates resistance to anti-PD1 therapy and improves antitumor immunity in glioblastoma. Proceedings of the National Academy of Sciences. 122(38). e2414941122–e2414941122.

Datta, Meenal, Laura E. Via, Véronique Dartois, et al.. (2024). Normalizing granuloma vasculature and matrix improves drug delivery and reduces bacterial burden in tuberculosis-infected rabbits. Proceedings of the National Academy of Sciences. 121(14). e2321336121–e2321336121. 10 indexed citations

Combes, Anna, Simon Vandekar, Ashwin S. Kumar, et al.. (2024). Biological variation in cervical spinal cord MRI morphometry in healthy individuals and people with multiple sclerosis. Journal of Neuroimaging. 34(4). 466–474.

Gomes‐Santos, Igor L., Ashwin S. Kumar, M. Meyer, et al.. (2024). Exercise intensity governs tumor control in mice with breast cancer. Frontiers in Immunology. 15. 1339232–1339232. 4 indexed citations

Kumar, Ashwin S., Ankit Agrawal, Lidiya Sul, et al.. (2024). Pericardial Disease in Cardiac Amyloidosis: A Comprehensive Review. The American Journal of Cardiology. 223. 100–108. 3 indexed citations

Boucher, Yves, Jessica M. Posada, Sonu Subudhi, et al.. (2023). Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Cancer Cells in Locally Advanced Pancreatic Cancer. Clinical Cancer Research. 29(8). 1605–1619. 30 indexed citations

Lei, Pin‐Ji, Ethel R. Pereira, Zohreh Amoozgar, et al.. (2023). Cancer cell plasticity and MHC-II–mediated immune tolerance promote breast cancer metastasis to lymph nodes. The Journal of Experimental Medicine. 220(9). 35 indexed citations

10.

Agrawal, Ankit, Ashwin S. Kumar, Mary Schleicher, et al.. (2023). Optimal antiplatelet strategy following coronary artery bypass grafting: a meta-analysis. Heart. 110(5). 323–330. 10 indexed citations

11.

Kumar, Ashwin S., Harjit Singh, Ankit Agrawal, et al.. (2023). IMMUNE-MEDIATED MYOCARDITIS FOLLOWING SINGLE DOSE OF ADJUVANT ATEZOLIZUMAB: DOES BENEFIT OUTWEIGH RISK?. Journal of the American College of Cardiology. 81(8). 2537–2537.

12.

Stephen, J, et al.. (2022). Antisense Molecules in Epilepsy—A Neuropharmacological Educational Review. 8(2). 44–51.

13.

Agrawal, Ankit, et al.. (2022). Abstract 14984: Transient Constrictive Pericarditis: Pericardiectomy to the Rescue. Circulation. 146(Suppl_1).

14.

Subburaju, Sivan, Pranay Goel, Jun Ren, et al.. (2022). Gabrb3 endothelial cell-specific knockout mice display abnormal blood flow, hypertension, and behavioral dysfunction. Scientific Reports. 12(1). 4922–4922. 8 indexed citations

15.

Agrawal, Ankit, et al.. (2022). IBRUTINIB INDUCED ATRIAL FIBRILLATION AND ITS ASSOCIATED MANAGEMENT. Journal of the American College of Cardiology. 79(9). 3361–3361. 1 indexed citations

16.

Boucher, Yves, Ashwin S. Kumar, Jessica M. Posada, et al.. (2021). Bevacizumab improves tumor infiltration of mature dendritic cells and effector T-cells in triple-negative breast cancer patients. npj Precision Oncology. 5(1). 62–62. 30 indexed citations

17.

Gomes‐Santos, Igor L., Zohreh Amoozgar, Ashwin S. Kumar, et al.. (2021). Exercise Training Improves Tumor Control by Increasing CD8+ T-cell Infiltration via CXCR3 Signaling and Sensitizes Breast Cancer to Immune Checkpoint Blockade. Cancer Immunology Research. 9(7). 765–778. 91 indexed citations

18.

Yamauchi, Junichiro, et al.. (2013). Triggering regeneration and tackling apoptosis: a combinatorial approach to treating congenital muscular dystrophy type 1 A. Human Molecular Genetics. 22(21). 4306–4317. 19 indexed citations

19.

Kumar, Ashwin S. & Pradeep Kumar. (2011). A New Framework for Color Image Segmentation Using Watershed Algorithm. Computer Engineering and Intelligent Systems. 2(3). 41–46. 7 indexed citations

20.

Kumar, Ashwin S., et al.. (2011). Muscle-specific expression of insulin-like growth factor 1 improves outcome in Lama2Dy-w mice, a model for congenital muscular dystrophy type 1A. Human Molecular Genetics. 20(12). 2333–2343. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact